Home · FSC 6505 Drugs And Biologicals · NSN 6505-01-642-0106

NSN 6505-01-642-0106 — Adenovirus Type 4 And Type 7 Vac

NIIN 01-642-0106 · unit of issue PG · AAC H (not stocked, central procurement (dispute)) · source of supply SMS

NSN 6505-01-642-0106 is the national stock number for an adenovirus type 4 and type 7 vac in federal supply class 6505 (Drugs And Biologicals). It cross-references to 3 manufacturer part numbers from 4 CAGE codes, including Barr Laboratories, Inc., Defense Logistics Agency Directorate Of Medical Materiel Defense Supply Center Philadelphia, Defense Medical Standardization Board; the primary is 1281637. The unit of issue is PG and the FLIS list price is $19,733.68.

The U.S. government has bought this item 7 times on record, 7 of them in the last 24 months, most recently on September 16, 2026 for $515,290 from Teva Pharmaceuticals Usa, Inc.. No seller has confirmed stock of it here in the last 60 days; watching the number is free and the first listing triggers an alert.

part numbers from 4 CAGEs

open solicitations, all agencies

government buys in 24 months

sellers with confirmed stock

Know someone who should see this?

Cross-references

Part numbers filed against this stock number, with the manufacturer (CAGE) and the FLIS reference codes.

Part number	CAGE	Manufacturer	Reference	Variation
NDC51285-0138-50	56490	Barr Laboratories, Inc.	3 · Design control (vendor)	2 · Fully interchangeable
1281637	89875	Defense Logistics Agency Directorate Of Medical Materiel Defense Supply Center Philadelphia	5 · Secondary reference	1 · Not fully interchangeable
6505NCM151649	64616	Defense Medical Standardization Board	5 · Secondary reference	1 · Not fully interchangeable
NDC51285-0138-50	3V8D7	Teva Pharmaceuticals Usa, Inc.	5 · Secondary reference	2 · Fully interchangeable

Government demand

Nothing open right now. Last government buy Sep 16, 2026. Watch this NSN and we will email you when it is solicited.

What the government paid

Date	Vendor	Amount	Buyer	Reference
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$515,290	Dla	SPE2DP20D0002
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$343,526	Dla	SPE2DP20D0002
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$687,053	Dla	SPE2DP20D0002
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$515,290	Dla	SPE2DP20D0002
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$343,526	Dla	SPE2DP20D0002
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$343,526	Dla	SPE2DP20D0002
Sep 16, 2026	Teva Pharmaceuticals Usa, Inc. 3V8D7	$171,763	Dla	SPE2DP20D0002

Sources: DLA DIBBS procurement history (unit cost), DLA award history, FPDS (all agencies), SAM.gov notices. 7 buys on record in total.

Sellers with confirmed stock

No seller has confirmed stock on this NSN in the last 60 days. Watch it and we will email you when one does, or request a quote on 1281637.

Listings appear here only while the seller has confirmed them within 60 days. Sellers: list this part free.

DLA management data

FLIS unit price: $19,733.68
Unit of issue: PG
Acquisition advice: H — Not stocked, central procurement (dispute)
Source of supply: SMS
Shelf life code: P
Effective: Dec 1, 2025

Item characteristics

Part Name Assigned By Controlling Agency: ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S
Special Features: CONTAINS VIABLE, SELECTED STRAINS OF HUMAN ADENOVIRUS TYPE 4 AND HUMAN ADENOVIRUS TYPE 7 PREPARED IN HUMAN-DIPLOID FIBROBLAST CELL CULTURES (STRAIN WI-38); VIRUS STRAINS HAVE NOT BEEN ATTENUATED; CELL

About this page

An NSN is 13 digits: the 4-digit Federal Supply Class and the 9-digit NIIN. Cross-references come from the federal logistics record; demand from DLA DIBBS, SAM.gov and FPDS; ADs from the Federal Register. Refreshed nightly. Market Pulse shows the whole market.